Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants.
about
Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccinesDNA vaccines: developing new strategies against cancer.Current progress in the development of a prophylactic vaccine for HIV-1.Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunityVaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferonDeveloping DNA vaccines that call to dendritic cells.Delivery of DNA HIV-1 vaccine to the liver induces high and long-lasting humoral immune responsesAdvances in FIV vaccine technology.Optimization and delivery of plasmid DNA for vaccination.The potential of topical DNA vaccines adjuvanted by cytokines.IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccineIncreased in vivo immunological potency of HB-110, a novel therapeutic HBV DNA vaccine, by electroporationModulation of the Immune Response to DNA Vaccine Encoding Gene of 8-kDa Subunit of Echinococcus granulosus Antigen B Using Murine Interleukin-12 Plasmid in BALB/c MiceModulation of HIV-1 immunity by adjuvants.Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications.Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag cDNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination.Enhanced anti-tumor effect of a gene gun-delivered DNA vaccine encoding the human papillomavirus type 16 oncoproteins genetically fused to the herpes simplex virus glycoprotein D.Antigen expression kinetics and immune responses of mice immunized with noninfectious simian-human immunodeficiency virus DNACombined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques.Oral immunogenicity of potato-derived antigens to Mycobacterium tuberculosis in mice.Differential polarization of immune responses by genetic cotransfer of chemokines changes the protective immunity of DNA vaccine against pseudorabies virus.Significant alterations of biodistribution and immune responses in Balb/c mice administered with adenovirus targeted to CD40(+) cells.Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo.
P2860
Q26827712-719D9270-982F-4B43-AEFA-A7796C0F7111Q33756622-C2C4C51B-E642-4CF7-8E5A-9A3D9053585DQ34502108-BD3C3296-80B7-4AA4-8829-D3440D064C84Q34705057-2F89C965-E728-43F3-96E3-21DEBBA4BFABQ35634911-006F90CC-8509-49E1-837B-E7BCDA3B4B46Q35634943-240BB05C-DE09-4DAF-B50D-E798D97DC771Q35936512-AEEA5183-13DA-410E-AE4C-750A081FF872Q36571388-E96E5210-4538-4529-B47E-24F7F5EA1DC2Q36634847-7CB2371D-583B-4AAE-97B4-9F8EE6C26050Q36690285-44B3B03D-5801-46F1-BB4A-42F7624E5915Q36960508-E1F97232-EEBE-431F-900F-3770139EF091Q36972168-3A8C9511-4684-4C11-88EC-85562FDE875CQ37184999-382A9827-2FCC-4B0A-B180-727B557CEED4Q37597012-B806EE0A-02B4-4648-A255-EACDE9B30CCCQ37698564-8F424518-92D1-4582-8BDD-A46D82C4E833Q37965727-91981A2D-A934-4A4E-8C4C-CC7D7CA2D696Q39028785-87E8530A-8E84-484B-B5B8-668BF3EC76D2Q39509643-EB6C6A91-5A9E-4A64-A827-D55750FDF5AEQ39766780-39124090-D6C8-47AA-8803-4AED08844520Q39797438-2CD97E72-8B09-49F9-AC42-18CE811CEA0BQ42410705-F4DB509D-1DDF-49B3-AC5A-893B685D3A02Q43909012-984CD251-13DE-45C0-8560-0A2845B5A631Q45409938-4A837B42-C859-47F4-9ADB-0E954006B8E4Q45873308-182B73F2-1713-446C-842F-14462E4C0642Q45889163-0BB404A7-3E29-49FD-8D19-86E07DF6068B
P2860
Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Enhancement of human immunodef ...... -helper 1 molecular adjuvants.
@ast
Enhancement of human immunodef ...... -helper 1 molecular adjuvants.
@en
type
label
Enhancement of human immunodef ...... -helper 1 molecular adjuvants.
@ast
Enhancement of human immunodef ...... -helper 1 molecular adjuvants.
@en
prefLabel
Enhancement of human immunodef ...... -helper 1 molecular adjuvants.
@ast
Enhancement of human immunodef ...... -helper 1 molecular adjuvants.
@en
P2860
P1476
Enhancement of human immunodef ...... -helper 1 molecular adjuvants.
@en
P2093
David B Weiner
Sandra A Calarota
P2860
P356
10.1111/J.0105-2896.2004.00150.X
P577
2004-06-01T00:00:00Z